Agilent Technologies (Santa Clara, California) plans to separate into two publicly traded companies: one in life sciences, diagnostics, and applied markets that will retain the Agilent name, and another that will encompass Agilent?s current portfolio of electronic measurement products.
Agilent Technologies (Santa Clara, California) plans to separate into two publicly traded companies: one in life sciences, diagnostics, and applied markets that will retain the Agilent name, and another that will encompass Agilent’s current portfolio of electronic measurement products.
The new electronic measurement company will be an electronic measurement company in major markets including communications, aerospace and defense, and industrial, computers, and semiconductors.
Agilent says it believes that the separation will result in material benefits to the standalone companies, including greater management focus on the distinct businesses of life sciences, diagnostics, and applied markets, and electronic measurement; ability for the life sciences, diagnostics, and applied markets company to devote resources to the higher-growth life sciences, diagnostics, and applied markets business, while reducing exposure to the more cyclical electronic measurement industry; ability for the electronic measurement company to devote resources to its own growth that were previously used to capitalize life sciences, diagnostics, and applied markets; and two independent and unique investment profiles. Additionally, both companies will be well capitalized, having strong balance sheets and investment-grade profiles with target debt-to-EBITDA ratios below 2.0x.
New Study Reviews Chromatography Methods for Flavonoid Analysis
April 21st 2025Flavonoids are widely used metabolites that carry out various functions in different industries, such as food and cosmetics. Detecting, separating, and quantifying them in fruit species can be a complicated process.
Quantifying Terpenes in Hydrodistilled Cannabis sativa Essential Oil with GC-MS
April 21st 2025A recent study conducted at the University of Georgia, (Athens, Georgia) presented a validated method for quantifying 18 terpenes in Cannabis sativa essential oil, extracted via hydrodistillation. The method, utilizing gas chromatography–mass spectrometry (GC–MS) with selected ion monitoring (SIM), includes using internal standards (n-tridecane and octadecane) for accurate analysis, with key validation parameters—such as specificity, accuracy, precision, and detection limits—thoroughly assessed. LCGC International spoke to Noelle Joy of the University of Georgia, corresponding author of this paper discussing the method, about its creation and benefits it offers the analytical community.